Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications
David E. Kandzari(Piedmont Atlanta Hospital), Bruno Farah, Joachim Weil, Tolga Agdirlioglu(Sana Klinikum), Michael Böhm(Saarland University), Ganpat G. Thakker, D. Konstantinidis(National and Kapodistrian University of Athens), Richard Anderson(University Hospital of Wales), Kazuomi Kario(Jichi Medical University), David P. Lee, Suhail Allaqaband, Carl Lomboy, Stuart Pocock(University of London), James W. Choi(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), James Coulson(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Benjamin Honton, Felix Mahfoud(Saarland University), Vanessa DeBruin(Medtronic (United States)), Angela L. Brown(Virginia Commonwealth University), Ashley Paul, Taisei Kobayashi(University of Pennsylvania), Michael A. Weber(SUNY Downstate Health Sciences University), Desmond Jay, Axel Schmid(Universitätsklinikum Erlangen), Raymond R. Townsend(University of Pennsylvania), Markus P. Schlaich(Friedrich-Alexander-Universität Erlangen-Nürnberg), Roland E. Schmieder, Bharat Gummadi, Debbie L. Cohen(University of Pennsylvania), Cara East(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Martin Fahy(Medtronic (United States)), Konstantinos Tsioufis(Hippocration General Hospital), Janice P. Lea, Fidel Garcia, Fuad Jan, Jasvindar Singh, Brent McLaurin(AnMed Health), Jiro Aoki, Chandan Devireddy, Yale Wang(Abbott Northwestern Hospital), Sandeep Brar(Medtronic (United States)), Andrew S.P. Sharp, Sharad Shetty(The University of Western Australia), Marc R. Litt, Adrian Ma(Stanford Health Care), Lucas Lauder, Aravinda Nanjundappa, James Campbell(Angkor Hospital for Children)
Cited by 115
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
|New England Journal of Medicine|2012|2.8k